Effects of dietary interventions on depressive symptom profiles: results from the MooDFOOD depression prevention study.
Diet
depression prevention
depressive symptom profiles
heterogeneity
Journal
Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142
Informations de publication
Date de publication:
07 Apr 2021
07 Apr 2021
Historique:
entrez:
7
4
2021
pubmed:
8
4
2021
medline:
8
4
2021
Statut:
aheadofprint
Résumé
Dietary interventions did not prevent depression onset nor reduced depressive symptoms in a large multi-center randomized controlled depression prevention study (MooDFOOD) involving overweight adults with subsyndromal depressive symptoms. We conducted follow-up analyses to investigate whether dietary interventions differ in their effects on depressive symptom profiles (mood/cognition; somatic; atypical, energy-related). Baseline, 3-, 6-, and 12-month follow-up data from MooDFOOD were used (n = 933). Participants received (1) placebo supplements, (2) food-related behavioral activation (F-BA) therapy with placebo supplements, (3) multi-nutrient supplements (omega-3 fatty acids and a multi-vitamin), or (4) F-BA therapy with multi-nutrient supplements. Depressive symptom profiles were based on the Inventory of Depressive Symptomatology. F-BA therapy was significantly associated with decreased severity of the somatic (B = -0.03, p = 0.014, d = -0.10) and energy-related (B = -0.08, p = 0.001, d = -0.13), but not with the mood/cognition symptom profile, whereas multi-nutrient supplementation was significantly associated with increased severity of the mood/cognition (B = 0.05, p = 0.022, d = 0.09) and the energy-related (B = 0.07, p = 0.002, d = 0.12) but not with the somatic symptom profile. Differentiating depressive symptom profiles indicated that food-related behavioral interventions are most beneficial to alleviate somatic symptoms and symptoms of the atypical, energy-related profile linked to an immuno-metabolic form of depression, although effect sizes were small. Multi-nutrient supplements are not indicated to reduce depressive symptom profiles. These findings show that attention to clinical heterogeneity in depression is of importance when studying dietary interventions.
Sections du résumé
BACKGROUND
BACKGROUND
Dietary interventions did not prevent depression onset nor reduced depressive symptoms in a large multi-center randomized controlled depression prevention study (MooDFOOD) involving overweight adults with subsyndromal depressive symptoms. We conducted follow-up analyses to investigate whether dietary interventions differ in their effects on depressive symptom profiles (mood/cognition; somatic; atypical, energy-related).
METHODS
METHODS
Baseline, 3-, 6-, and 12-month follow-up data from MooDFOOD were used (n = 933). Participants received (1) placebo supplements, (2) food-related behavioral activation (F-BA) therapy with placebo supplements, (3) multi-nutrient supplements (omega-3 fatty acids and a multi-vitamin), or (4) F-BA therapy with multi-nutrient supplements. Depressive symptom profiles were based on the Inventory of Depressive Symptomatology.
RESULTS
RESULTS
F-BA therapy was significantly associated with decreased severity of the somatic (B = -0.03, p = 0.014, d = -0.10) and energy-related (B = -0.08, p = 0.001, d = -0.13), but not with the mood/cognition symptom profile, whereas multi-nutrient supplementation was significantly associated with increased severity of the mood/cognition (B = 0.05, p = 0.022, d = 0.09) and the energy-related (B = 0.07, p = 0.002, d = 0.12) but not with the somatic symptom profile.
CONCLUSIONS
CONCLUSIONS
Differentiating depressive symptom profiles indicated that food-related behavioral interventions are most beneficial to alleviate somatic symptoms and symptoms of the atypical, energy-related profile linked to an immuno-metabolic form of depression, although effect sizes were small. Multi-nutrient supplements are not indicated to reduce depressive symptom profiles. These findings show that attention to clinical heterogeneity in depression is of importance when studying dietary interventions.
Identifiants
pubmed: 33823960
doi: 10.1017/S0033291721000337
pii: S0033291721000337
pmc: PMC9772915
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-10Commentaires et corrections
Type : CommentIn
Références
J Clin Psychol. 2006 Jan;62(1):123-46
pubmed: 16287149
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
J Affect Disord. 2013 May;147(1-3):355-64
pubmed: 23246363
BMC Med. 2013 May 15;11:129
pubmed: 23672628
Br J Psychiatry. 2014 Oct;205(4):268-74
pubmed: 25274315
Psychol Med. 2017 Feb;47(3):543-552
pubmed: 27786143
J Affect Disord. 2010 Sep;125(1-3):146-54
pubmed: 20074811
Psychol Med. 2018 May;48(7):1102-1110
pubmed: 28889804
J Clin Epidemiol. 2003 Dec;56(12):1163-9
pubmed: 14680666
Front Psychiatry. 2019 Nov 21;10:858
pubmed: 31824355
J Am Coll Cardiol. 2011 Mar 15;57(11):1299-313
pubmed: 21392646
Br J Psychiatry. 2017 Feb;210(2):110-118
pubmed: 27810893
Psychol Med. 2020 Aug;50(11):1872-1883
pubmed: 31409435
J Psychosom Res. 2020 Jul 30;137:110206
pubmed: 32798835
Psychosom Med. 2019 Apr;81(3):265-280
pubmed: 30720698
J Psychosom Res. 2018 May;108:85-92
pubmed: 29602330
Sleep Med Rev. 2018 Aug;40:170-182
pubmed: 29366543
Psychol Med. 1996 May;26(3):477-86
pubmed: 8733206
World Psychiatry. 2017 Oct;16(3):287-298
pubmed: 28941113
Nutrients. 2018 Jan 10;10(1):
pubmed: 29320413
Ann Behav Med. 2010 May;39(2):128-38
pubmed: 20422333
J Clin Psychiatry. 2010 Dec;71(12):1582-9
pubmed: 20673552
Lancet. 2012 Dec 15;380(9859):2197-223
pubmed: 23245608
Psychosom Med. 2013 Feb;75(2):144-53
pubmed: 23362497
World Psychiatry. 2019 Oct;18(3):308-324
pubmed: 31496103
Nutr Metab Cardiovasc Dis. 2014 Sep;24(9):929-39
pubmed: 24787907
Prog Cardiovasc Dis. 2015 Jul-Aug;58(1):50-60
pubmed: 25940230
J Affect Disord. 2015 Feb 1;172:96-102
pubmed: 25451401
JAMA. 2019 Mar 5;321(9):858-868
pubmed: 30835307
Obes Surg. 2008 Jul;18(7):870-6
pubmed: 18465178
J Affect Disord. 2002 Apr;68(2-3):273-84
pubmed: 12063155
Mol Psychiatry. 2019 Jul;24(7):965-986
pubmed: 30254236
Brain Behav Immun. 2020 Aug;88:174-183
pubmed: 32272220
Eur Arch Psychiatry Clin Neurosci. 2014 Oct;264(7):577-88
pubmed: 24292327
Biol Psychiatry. 2020 Sep 1;88(5):369-380
pubmed: 32247527
BMC Psychiatry. 2013 Sep 12;13:223
pubmed: 24028572
BMC Psychiatry. 2016 Jun 08;16:192
pubmed: 27277946
Br J Psychiatry. 2009 Mar;194(3):252-9
pubmed: 19252156
Eur J Nutr. 2020 Sep;59(6):2579-2591
pubmed: 31642985
Lancet. 2015 Nov 28;386(10009):2145-91
pubmed: 26321261
J Psychiatr Res. 2018 Feb;97:38-46
pubmed: 29175296
J Affect Disord. 2018 Jan 15;226:346-354
pubmed: 29031185
Expert Rev Neurother. 2017 May;17(5):423-425
pubmed: 28293960
Psychother Psychosom. 2020;89(1):48
pubmed: 31655818
Psychother Psychosom. 2019;88(5):263-273
pubmed: 31480057